Member Info for maximillion69

Thanks Tyke

Totally agree with that .

Also through Semantic s prompt

2. Financial Disclosures (Market Impact)

Since many Phase 1 trials are conducted by publicly traded biotech or pharma companies, the "public" often hears the results first through Investor Relations.

Press Releases: If a Phase 1 trial shows "positive safety data" or "favorable pharmacokinetics," the company will issue a press release to boost stock confidence.

Relate this to the last RNS regarding share holder values , why wouldn’t results be advised ?

Let’s consider all the stages that was RNS

Https://www.linkedin.com/posts/michael-sheffield-8570a2138_greenconstruction-hydrogenpower-innovation-activity-7428010802286272512-dp2q?utm_source=share&utm_medium=member_ios&rcm=ACoAAAkyjQ0B7bMMkoLn8XD8s2HLk9vizWE-zfc

Https://www.google.com/search?q=can+you+value+a+drug+companys+IP+%3F+phase+1+complete%2C+2+Orphan+Drug+Designations.+2+Rare+Pediatric+Drug+Designations+and+Fast+Track+Designation.+Imaging+Biometrics.+%2C+%C2%A0Gallium+Maltolate%C2%A0&client=safari&hs=CU09&sca_esv=db6a961703d37008&hl=en-gb&channel=31&biw=414&bih=747&sxsrf=ANbL-n5hvpglj1z1gh6zi5BUR4m507fXmQ%3A1770927889891&ei=ETeOaZyPNsK5hbIP4oSkkAI&sclient=mobile-gws-wiz-serp&udm=50&fbs=ADc_l-byipRaccqV0jmfPhi1DgzPtklXGmVkws8Z_lBff884vwWzYGOXmwhR8m6ZBpcqcPIygX2pO_pfNpUEhZEK-M0M9IwnsdwtVYQFpGCSsq0wWzRZgcwzFO2quNXM4Og3CCSBsgEGPS2yjygnBv3b_ew27HdzN0G1iZtcYWZjtV9BsTEQPQyec1FsiTjdUUqPnNhAew96mNaE53St7L73ZwIsARc4ZFyPEjXZ5-cj4dySTITPdYY&aep=10&ntc=1&mstk=AUtExfAWfGYcUGRJ8lGLblpHeohpIk6OH33pv-7cJAG1LJE2iORJf7CyJM1G9ocu6aR-0EEUqRrbUWLYqSYJLZQ-hWQitLw9TMFc-AfPTyfsWiRbJWUAxd14aVXzNt55lySsZeGj4BAhz-ba4cyrFMWP615XHJA2JUtA2bdVjougzcGOlLLYavLIiHN74Dh2mpw7DSusmF_dP1icDylX4wYtavc6o3Yinyn3nlchp2q81AIQWXX5Zm7VHuRSpMCiQTtkdCUCjYeS0JaPVQdanHHsOIp_VoPHKPXLYSokp90eLy32zW5UNdHXWFeDKN9Prz3Sr2yaVDIhvAwOHA&csuir=1&mtid=zjeOaf2UHPmmhbIPl_XIwQk#lfId=ChxjMe

Tyke

Do you think full results will be reported tomorrow ?

There is a small value to GaM as i am sure IB get paid for EAP but we didn't get updated on EAP 😩

.4265 to sell

.54. To buy. Real spread about 27%.

Reduce the sell.

But upped the buy

Phase 1 results

if IB have knowledge of results surely they should be reported being price sensitive news.

other than a few financial notes not much here .

sorry

sceptical regarding Phase 1 results , no mention of EAP

Https://www.londonstockexchange.com/news-article/IBAI/update-and-ib-nimble-webinar-27-february-2026/17455454

Mms will take 1.4 m. Which is very rare here. Kane can you please give me thoughts ?

Tyke

No not had any response from Mike I may of been a bit unsociable on my last email . I have asked on direct message linked in regarding standing of Designations regarding Gabriel trial but nothing coming my way .

Any faster they would stop ! Fast Track 🤦‍♂️

Plenty of time to spend developing imaging Tech/ marketing if not too late !!!

Https://x.com/imgbiometrics/status/2019472470453936361?s=46

Any trading gurus

Why a 30% spread , Nobody’s buying into that

What’s stoping MCW applying for ODD , RPDD etc for GaM ? Race is for approval ,

The Why question , Is why a Pediatric trial wasn’t programmed in , I’m sure it was mentioned in an RNS

Cautious

I’m lost to where we stand having 2 RPDD for GaM but not the sponsors of a Peduatric trial ? Tyke do you think you could ask Trev ?

Https://everylifefoundation.org/congress-passes-five-year-reauthorization-of-rare-pediatric-disease-prv-program/

Https://x.com/imgbiometrics/status/2018397767421579341?s=46